BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2549463)

  • 41. NMDA receptor antagonists disrupt the retinotectal topographic map.
    Cline HT; Constantine-Paton M
    Neuron; 1989 Oct; 3(4):413-26. PubMed ID: 2577128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.
    Wong EH; Kemp JA; Priestley T; Knight AR; Woodruff GN; Iversen LL
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7104-8. PubMed ID: 3529096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacological selectivity of three NMDA antagonists.
    Childs AM; Evans RH; Watkins JC
    Eur J Pharmacol; 1988 Jan; 145(1):81-6. PubMed ID: 2894999
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-methyl-D-aspartate (NMDA) receptors control respiratory off-switch in cat.
    Foutz AS; Champagnat J; Denavit-Saubié M
    Neurosci Lett; 1988 May; 87(3):221-6. PubMed ID: 2837690
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of NMDA antagonists in the radial arm maze task with an interposed delay.
    Butelman ER
    Pharmacol Biochem Behav; 1990 Mar; 35(3):533-6. PubMed ID: 2160086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection by NMDA antagonists against selective cell loss following transient ischaemia.
    Swan JH; Meldrum BS
    J Cereb Blood Flow Metab; 1990 May; 10(3):343-51. PubMed ID: 2158499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective N-methyl-D-aspartate (NMDA) antagonists increase gastric motility in the rat.
    Shinozaki H; Gotoh Y; Ishida M
    Neurosci Lett; 1990 May; 113(1):56-61. PubMed ID: 1973272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacologically distinct glutamate receptors on cerebellar granule cells.
    Drejer J; Honoré T; Meier E; Schousboe A
    Life Sci; 1986 Jun; 38(23):2077-85. PubMed ID: 2872566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attenuation of febrile seizures in epileptic chicks by N-methyl-D-aspartate receptor antagonists.
    Pedder SC; Wilcox RI; Tuchek JM; Johnson DD; Crawford RD
    Can J Physiol Pharmacol; 1990 Jan; 68(1):84-8. PubMed ID: 2158387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
    Carter CJ; Lloyd KG; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MK-801 prevents cognitive and behavioral deficits produced by NMDA receptor overstimulation in the rat hippocampus.
    Rogers BC; Tilson HA
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):445-53. PubMed ID: 2546291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebellar granule cell survival and maturation induced by K+ and NMDA correlate with c-fos proto-oncogene expression.
    Didier M; Roux P; Piechaczyk M; Verrier B; Bockaert J; Pin JP
    Neurosci Lett; 1989 Dec; 107(1-3):55-62. PubMed ID: 2575730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactive effects involving different classes of excitatory amino acid receptors and the survival of cerebellar granule cells in culture.
    Balázs R; Hack N; Jørgensen OS
    Int J Dev Neurosci; 1990; 8(4):347-59. PubMed ID: 2174632
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential modulation of the associated glycine recognition site by competitive N-methyl-D-aspartate receptor antagonists.
    Monahan JB; Biesterfeldt JP; Hood WF; Compton RP; Cordi AA; Vazquez MI; Lanthorn TH; Wood PL
    Mol Pharmacol; 1990 Jun; 37(6):780-4. PubMed ID: 2163012
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use.
    Kurumaji A; Nehls DG; Park CK; McCulloch J
    Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel NMDA antagonist, MK-801, impairs performance in a hippocampal-dependent spatial learning task.
    Butelman ER
    Pharmacol Biochem Behav; 1989 Sep; 34(1):13-6. PubMed ID: 2696982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A potential role for excitotoxins in the pathophysiology of spinal cord injury.
    Faden AI; Simon RP
    Ann Neurol; 1988 Jun; 23(6):623-6. PubMed ID: 2841902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of the anticonvulsant effects of competitive and non-competitive antagonists of the N-methyl-D-aspartate receptor.
    Nevins ME; Arnolde SM
    Brain Res; 1989 Nov; 503(1):1-4. PubMed ID: 2558775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute excitotoxicity in chick retina caused by the unusual amino acids BOAA and BMAA: effects of MK-801 and kynurenate.
    Zeevalk GD; Nicklas WJ
    Neurosci Lett; 1989 Jul; 102(2-3):284-90. PubMed ID: 2554210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.